Larvol Delta - Complement-Inhibition-Should-Be-Considered-Before-Nefecon-in-Patients-With-IgAN-at-Risk-of-Progression

Tarpeyo (budesonide) - Calliditas, Stada

https://events.theisn.org/event/session/view/50981:0

Vlado Perkovic

Feb 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next